Literature DB >> 17552023

Hepatitis C virus proteins.

Jean Dubuisson1.   

Abstract

Hepatitis C virus (HCV) encodes a single polyprotein, which is processed by cellular and viral proteases to generate 10 polypeptides. The HCV genome also contains an overlapping +1 reading frame that may lead to the synthesis of an additional protein. Until recently, studies of HCV have been hampered by the lack of a productive cell culture system. Since the identification of HCV genome approximately 17 years ago, structural, biochemical and biological information on HCV proteins has mainly been obtained with proteins produced by heterologous expression systems. In addition, some functional studies have also been confirmed with replicon systems or with retroviral particles pseudotyped with HCV envelope glycoproteins. The data that have accumulated on HCV proteins begin to provide a framework for understanding the molecular mechanisms involved in the major steps of HCV life cycle. Moreover, the knowledge accumulated on HCV proteins is also leading to the development of antiviral drugs among which some are showing promising results in early-phase clinical trials. This review summarizes the current knowledge on the functions and biochemical features of HCV proteins.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17552023      PMCID: PMC4146758          DOI: 10.3748/wjg.v13.i17.2406

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  148 in total

Review 1.  Salient molecular features of hepatitis C virus revealed.

Authors:  Christoph Seeger
Journal:  Trends Microbiol       Date:  2005-09-08       Impact factor: 17.079

2.  Hitching RIG to action.

Authors:  Ganes C Sen; Saumendra N Sarkar
Journal:  Nat Immunol       Date:  2005-11       Impact factor: 25.606

3.  RNA translocation and unwinding mechanism of HCV NS3 helicase and its coordination by ATP.

Authors:  Sophie Dumont; Wei Cheng; Victor Serebrov; Rudolf K Beran; Ignacio Tinoco; Anna Marie Pyle; Carlos Bustamante
Journal:  Nature       Date:  2006-01-05       Impact factor: 49.962

4.  Basic residues in hypervariable region 1 of hepatitis C virus envelope glycoprotein e2 contribute to virus entry.

Authors:  Nathalie Callens; Yann Ciczora; Birke Bartosch; Ngoc Vu-Dac; François-Loïc Cosset; Jean-Michel Pawlotsky; François Penin; Jean Dubuisson
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

5.  Signal peptide cleavage and internal targeting signals direct the hepatitis C virus p7 protein to distinct intracellular membranes.

Authors:  Stephen Griffin; Dean Clarke; Christopher McCormick; David Rowlands; Mark Harris
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

6.  Human monoclonal antibodies that react with the E2 glycoprotein of hepatitis C virus and possess neutralizing activity.

Authors:  Darren J Schofield; Birke Bartosch; Yohko K Shimizu; Tobias Allander; Harvey J Alter; Suzanne U Emerson; François-Loïc Cosset; Robert H Purcell
Journal:  Hepatology       Date:  2005-11       Impact factor: 17.425

7.  Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders.

Authors:  Domenico Rosa; Giulietta Saletti; Ennio De Gregorio; Francesca Zorat; Consuelo Comar; Ugo D'Oro; Sandra Nuti; Michael Houghton; Vincenzo Barnaba; Gabriele Pozzato; Sergio Abrignani
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-09       Impact factor: 11.205

8.  Down-regulation of the retinoblastoma tumor suppressor by the hepatitis C virus NS5B RNA-dependent RNA polymerase.

Authors:  Tsubasa Munakata; Mitsuyasu Nakamura; Yuqiong Liang; Kui Li; Stanley M Lemon
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-06       Impact factor: 11.205

9.  Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity.

Authors:  Xiao-Dong Li; Lijun Sun; Rashu B Seth; Gabriel Pineda; Zhijian J Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-21       Impact factor: 11.205

10.  Hepatitis C virus nonstructural protein 5A (NS5A) is an RNA-binding protein.

Authors:  Luyun Huang; Jungwook Hwang; Suresh D Sharma; Michele R S Hargittai; Yingfeng Chen; Jamie J Arnold; Kevin D Raney; Craig E Cameron
Journal:  J Biol Chem       Date:  2005-08-25       Impact factor: 5.157

View more
  50 in total

1.  The acidic sequence of the NS4A cofactor regulates ATP hydrolysis by the HCV NS3 helicase.

Authors:  Sergey A Shiryaev; Andrei V Chernov; Tatiana N Shiryaeva; Alexander E Aleshin; Alex Y Strongin
Journal:  Arch Virol       Date:  2010-10-27       Impact factor: 2.574

2.  Functional characterization of core genes from patients with acute hepatitis C virus infection.

Authors:  Xi Tang; Jessica Wagoner; Amina Negash; Michael Austin; John McLauchlan; Young S Hahn; Hugo R Rosen; Stephen J Polyak
Journal:  J Infect Dis       Date:  2010-03-15       Impact factor: 5.226

3.  Hepatitis C virus replication and potential targets for direct-acting agents.

Authors:  Jacqueline G O'Leary; Gary L Davis
Journal:  Therap Adv Gastroenterol       Date:  2010-01       Impact factor: 4.409

4.  Patch-Clamp Study of Hepatitis C p7 Channels Reveals Genotype-Specific Sensitivity to Inhibitors.

Authors:  Ulrike Breitinger; Noha S Farag; Nourhan K M Ali; Hans-Georg A Breitinger
Journal:  Biophys J       Date:  2016-06-07       Impact factor: 4.033

5.  Interplay among cellular polarization, lipoprotein metabolism and hepatitis C virus entry.

Authors:  Ignacio Benedicto; Francisca Molina-Jiménez; Ricardo Moreno-Otero; Manuel López-Cabrera; Pedro L Majano
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

6.  Identification of ligands that target the HCV-E2 binding site on CD81.

Authors:  Reem Al Olaby; Hassan M Azzazy; Rodney Harris; Brett Chromy; Jost Vielmetter; Rod Balhorn
Journal:  J Comput Aided Mol Des       Date:  2013-04-24       Impact factor: 3.686

7.  Potent inhibitors of hepatitis C core dimerization as new leads for anti-hepatitis C agents.

Authors:  Feng Ni; Smitha Kota; Virginia Takahashi; A Donny Strosberg; John K Snyder
Journal:  Bioorg Med Chem Lett       Date:  2011-04-15       Impact factor: 2.823

8.  Identification of GBF1 as a cellular factor required for hepatitis C virus RNA replication.

Authors:  Lucie Goueslain; Khaled Alsaleh; Pauline Horellou; Philippe Roingeard; Véronique Descamps; Gilles Duverlie; Yann Ciczora; Czeslaw Wychowski; Jean Dubuisson; Yves Rouillé
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

9.  Blocking hepatitis C virus infection with recombinant form of envelope protein 2 ectodomain.

Authors:  Jillian Whidby; Guaniri Mateu; Hannah Scarborough; Borries Demeler; Arash Grakoui; Joseph Marcotrigiano
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

Review 10.  Drugs in development for hepatitis C.

Authors:  Rudolf E Stauber; Harald H Kessler
Journal:  Drugs       Date:  2008       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.